Abstract:
Purpose of review:
Diffuse cystic lung diseases (DCLDs) are a heterogeneous group of
disorders with varying pathophysiologic mechanisms that are
characterized by the presence of air-filled lung cysts. These cysts
are prone to rupture, leading to the development of recurrent
spontaneous pneumothoraces. In this article, we review the
epidemiology, clinical features, and management DCLD-associated
spontaneous pneumothorax, with a focus on lymphangioleiomyomatosis,
Birt–Hogg–Dubé syndrome, and pulmonary Langerhans cell
histiocytosis.
Recent findings:
DCLDs are responsible for approximately 10% of apparent primary
spontaneous pneumothoraces. Computed tomography screening for DCLDs
(Birt–Hogg–Dubé syndrome, lymphangioleiomyomatosis, and
pulmonary Langerhans cell histiocytosis) following the first
spontaneous pneumothorax has recently been shown to be cost-effective
and can help facilitate early diagnosis of the underlying disorders.
Patients with DCLD-associated spontaneous pneumothorax have a very
high rate of recurrence, and thus pleurodesis should be considered
following the first episode of spontaneous pneumothorax in these
patients, rather than waiting for a recurrent episode. Prior
pleurodesis is not a contraindication to future lung transplant.
Summary: Although
DCLDs are uncommon, spontaneous pneumothorax is often the sentinel
event that provides an opportunity for diagnosis. By understanding
the burden and implications of pneumothoraces in DCLDs, clinicians
can facilitate early diagnosis and appropriate management of the
underlying disorders.
No comments:
Post a Comment